KAPA Earnings Kairos Pharma, LTD.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -0.08 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.30 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.23 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.16 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.08 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.23 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -0.15 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.05 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.03 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.17 | 2025-04-15 | 10-K |
| Q3 2024 | 2023-09-30 | -0.07 | 2024-11-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.